Expands Global Test Centre For Medical Devices In Penang
KUALALUMPUR : German-based medical technology
company, B. Braun will expand its portfolio of testing capabilities for
healthcare solutions related to intravenous access, surgical technologies,
intravenous systems, central venous puncture and pain control in Penang.
In a joint statement, the Malaysian Investment
Development Authority (MIDA) and B. Braun said the volume of product testing has
been tripled to more than 600,000 scientific measurements per annum due to the
proven competencies, strong product knowledge and efficiency displayed by the
local team of Malaysian engineers.
Furthermore, they said medical devices for infusion
systems, central venous puncture and pain control, which are being manufactured
in Germany, have also been added to the portfolio being tested in Penang.
The Global Test Centre would conduct design
validation, discovery and shelf life testing, as well as failure analysis; and
features state-of-the-art test equipment and a fully integrated data management
system, which is crucial to ensure the safety and efficacy of medical devices,
used in the treatment of patients around the world.
All products are also tested to ensure adherence to
the stringent requirements of the European Medical Device Regulation (EU MDR),
United States Food & Drug Administration (US FDA) and other recognised
MIDA chief executive officer, Datuk Azman Mahmud
said the Malaysian medical device industry has shown great promise in creating
high-quality employment, reinforcing the domestic supply chain ecosystem, and
generating greater export value.
"We have a strong presence of established supporting
industries conforming to world-class standards that support the medical devices
industry in the country.
"The nation’s legacy expertise in precision
electronics has also provided our workforce the requisite skills in quality
management and precision. We trust that these qualities draw world leaders in
healthcare including B. Braun to continuously embrace the abundant business
opportunities in Malaysia today,” he added.
Meanwhile, B. Braun Asia Pacific president, Lam Chee
Hong said the Global Test Centre in Penang, which is staffed by a proven team of
highly competent Malaysians, would ensure that patients everywhere continue to
receive medical devices of the highest global standards.
Occupying a 193,285 square metre site in Penang’s
Free Industrial Zone, B. Braun Medical Industries is one of the largest
production sites of the Group, with over 7,600 employees.
Established in 1972, B. Braun is a pioneer foreign
investor in the northern state, which has evolved into the nexus for the medical
device industry in Malaysia. - Bernama.